Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 3 | — | — |
testing negative for chicken pox immunity; This spontaneous report was received from the patient's mother, concerning her daughter, a female patient of unknown age. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On an unknown date in 2011, the patient was vaccinated with two doses of with varicella virus vaccine live (oka/merck) (VARIVAX) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). On an unknown date, the patient was given a third dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, 1st dose, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) due to receiving testing and testing negative for chicken pox immunity. At the time of reporting, the outcome of the event testing negative for chicken pox immunity was not known. The causal relationship between testing negative for chicken pox immunity and varicella virus vaccine live (oka/merck) (VARIVAX) was unknown. Lot # is being requested and will be submitted if received.